Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Biomed Opt ; 7(4): 546-54, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12421120

ABSTRACT

We investigate optoelectronic properties of integrated structures comprising semiconductor light-emitting materials for optical probes of microscopic biological systems. Compound semiconductors are nearly ideal light emitters for probing cells and other microorganisms because of their spectral match to the transparency wavelengths of biomolecules. Unfortunately, the chemical composition of these materials is incompatible with the biochemistry of cells and related biofluids. To overcome these limitations, we investigate functionalized semiconductor surfaces and structures to simultaneously enhance light emission and the flow of biological fluids in semiconductor microcavities. We have identified several important materials problems associated with the semiconductor/biosystem interface. One is the biofluid degradation of electroluminescence by ionic diffusion into compound semiconductors. Ions that diffuse into the active region of a semiconductor light emitter can create point defects that degrade the quantum efficiency of the radiative recombination process. In this paper we discuss ways of mitigating these problems using materials design and surface chemistry, and suggest future applications for these materials.


Subject(s)
Biocompatible Materials , Optics and Photonics/instrumentation , Semiconductors , Animals , Biotechnology , Cells, Cultured , Dimethylpolysiloxanes , Electronics, Medical/instrumentation , Humans , Materials Testing , Prostheses and Implants , Rats , Silicones , Spectrometry, Mass, Secondary Ion
2.
Can J Microbiol ; 47(11): 969-78, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11766057

ABSTRACT

The influence of phosphite (H2PO3-) on the response of Saccharomyces cerevisiae to orthophosphate (HPO4(2-); Pi) starvation was assessed. Phosphate-repressible acid phosphatase (rAPase) derepression and cell development were abolished when phosphate-sufficient (+Pi) yeast were subcultured into phosphate-deficient (-Pi) media containing 0.1 mM phosphite. By contrast, treatment with 0.1 mM phosphite exerted no influence on rAPase activity or growth of +Pi cells. 31P NMR spectroscopy revealed that phosphite is assimilated and concentrated by yeast cultured with 0.1 mM phosphite, and that the levels of sugar phosphates, pyrophosphate, and particularly polyphosphate were significantly reduced in the phosphite-treated -Pi cells. Examination of phosphite's effects on two PHO regulon mutants that constitutively express rAPase indicated that (i) a potential target for phosphite's action in -Pi yeast is Pho84 (plasmalemma high-affinity Pi transporter and component of a putative phosphate sensor-complex), and that (ii) an additional mechanism exists to control rAPase expression that is independent of Pho85 (cyclin-dependent protein kinase). Marked accumulation of polyphosphate in the delta pho85 mutant suggested that Pho85 contributes to the control of polyphosphate metabolism. Results are consistent with the hypothesis that phosphite obstructs the signaling pathway by which S. cerevisiae perceives and responds to phosphate deprivation at the molecular level.


Subject(s)
Fungal Proteins/analysis , Phosphates/deficiency , Phosphates/metabolism , Phosphites/metabolism , Phosphorus/chemistry , Phosphorus/metabolism , Regulon , Saccharomyces cerevisiae/metabolism , Acclimatization , Acid Phosphatase/metabolism , Alcohol Dehydrogenase/metabolism , Pyruvate Kinase/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/growth & development , Signal Transduction
3.
J Am Dent Assoc ; 112(1): 60-2, 1986 Jan.
Article in English | MEDLINE | ID: mdl-3080507

ABSTRACT

A report of an anaphylactic reaction to oral penicillin is presented; the relative pharmacologic reactions are reviewed; the initial signs and symptoms are analyzed; and a successful treatment method is described.


Subject(s)
Anaphylaxis/therapy , Penicillin V/adverse effects , Administration, Oral , Anaphylaxis/chemically induced , Epinephrine/therapeutic use , Glucose/administration & dosage , Humans , Male , Middle Aged , Oxygen Inhalation Therapy , Penicillin V/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...